Geron Corporation (LON: 0IV3)
London
· Delayed Price · Currency is GBP · Price in USD
2.909
+0.020 (0.69%)
Jan 31, 2025, 6:25 PM BST
Geron Employees
Geron had 141 employees as of December 31, 2023. The number of employees increased by 34 or 31.78% compared to the previous year.
Employees
141
Change (1Y)
34
Growth (1Y)
31.78%
Revenue / Employee
155.99K GBP
Profits / Employee
-1.06M GBP
Market Cap
1.40B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Geron News
- 11 days ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 16 days ago - Geron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO Sales - Seeking Alpha
- 20 days ago - Geron updates on Q4 revenue from U.S. sales of RYTELO - Seeking Alpha
- 6 weeks ago - Geron Corp (GERN) Grants Stock Options to New Employees - GuruFocus
- 6 weeks ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Geron Corp (GERN) Receives Positive CHMP Opinion for RYTELO in Treating Blood Cancer - GuruFocus
- 7 weeks ago - Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Benzinga
- 7 weeks ago - Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Business Wire